NCT00907322View on ClinicalTrials.gov

A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

Dimebon

Oral tablet; 20 mg Dimebon, single dose

DRUG

Dimebon

Oral tablet; 40 mg Dimebon, single dose

DRUG

Dimebon

Oral tablet; 60 mg Dimebon, single dose

DRUG

Dimebon

Oral tablet; placebo, single dose

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer

Collaborators (1)

Medivation, Inc.
All Listed Sponsors
collaborator

Medivation, Inc.

INDUSTRY

lead

Pfizer

INDUSTRY